Department of Neuroradiology, Reims University Hospital, Reims, France.
Radiology. 2010 Sep;256(3):916-23. doi: 10.1148/radiol.10092209.
To analyze the clinical and anatomic factors that affect the occurrence and outcome of complications (thromboembolic events and intraoperative rupture) in the endovascular treatment of ruptured intracranial aneurysms in a large multicenter series, the CLARITY study (Clinical and Anatomic Results in the Treatment of Ruptured Intracranial Aneurysms).
This study was approved by the institutional review boards of the participating centers, and written informed consent was obtained from all patients. In the CLARITY series, 782 patients (314 men, 468 women; age range, 19-80 years, mean age, 51.3 years +/- 13.2 [standard deviation]) with 782 ruptured aneurysms underwent endovascular treatment for ruptured intracranial aneurysms at 20 institutions. Uni- and multivariate analyses were performed to determine factors (demographic characteristics, risk factors, anatomic factors, and therapeutic factors) that affect the occurrence of treatment-related complications.
A higher rate of thromboembolic events was observed in patients with aneurysms larger than 10 mm (28.0% vs 10.7% in patients with aneurysms < or =10 mm, P < .001), in smokers (16.1% vs 10.1% in nonsmokers, P = .015), and in patients with aneurysms with a neck larger than 4 mm (20.8% vs 11.0% in aneurysms with a neck < or =4 mm, P = .004).The frequency of intraoperative rupture was higher in patients with middle cerebral artery (MCA) aneurysms (8.5% vs 3.7% in patients without MCA aneurysms, P = .029), in patients younger than 65 years (5.0% vs 0.8% in patients older than 65 years, P = .032), and in patients without hypertension (5.4% vs 1.5% in patients with hypertension, P = .017).
The rate of thromboembolic events in the endovascular treatment of ruptured aneurysms is significantly affected by aneurysm size and neck size but not by aneurysm location. Conversely, the rate of intraoperative rupture is significantly affected by aneurysm location but not aneurysm size.
在 CLARITY 研究(颅内破裂动脉瘤治疗的临床和解剖学结果)中,分析影响血管内治疗破裂颅内动脉瘤的并发症(血栓栓塞事件和术中破裂)发生和结果的临床和解剖学因素。
该研究得到了参与中心机构审查委员会的批准,并获得了所有患者的书面知情同意。在 CLARITY 系列中,20 家机构对 782 例(314 例男性,468 例女性;年龄 19-80 岁,平均年龄 51.3 岁 +/- 13.2[标准差])782 例破裂性动脉瘤患者进行了血管内治疗破裂性颅内动脉瘤。进行了单因素和多因素分析,以确定影响治疗相关并发症发生的因素(人口统计学特征、危险因素、解剖学因素和治疗因素)。
发现动脉瘤大于 10mm 的患者血栓栓塞事件发生率较高(28.0% vs 10.7%,动脉瘤≤10mm,P<.001),吸烟者(16.1% vs 10.1%,非吸烟者,P=.015)和颈宽大于 4mm 的动脉瘤患者(20.8% vs 颈宽≤4mm 的动脉瘤患者,11.0%,P=.004)。MCA 动脉瘤患者术中破裂的频率较高(8.5% vs 无 MCA 动脉瘤患者,3.7%,P=.029),年龄小于 65 岁的患者(5.0% vs 年龄大于 65 岁的患者,0.8%,P=.032)和无高血压的患者(5.4% vs 高血压患者,1.5%,P=.017)。
血管内治疗破裂动脉瘤的血栓栓塞事件发生率明显受动脉瘤大小和颈部大小的影响,但不受动脉瘤位置的影响。相反,术中破裂的发生率明显受动脉瘤位置的影响,而不受动脉瘤大小的影响。